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Croton sphaerogynus is a shrub from the Atlantic Rain Forest in southeastern Brazil. A lyophilized crude EtOH extract from leaves
of C. sphaerogynus, obtained by maceration at room temperature (seven days), was suspended in methanol and partitioned with
hexane. The purified MeOH phase was fractionated over Sephadex LH-20 yielding five fractions (F1–F5) containing flavonoids, as
characterized by HPLC-DAD and HPLC-MS analyses. The antiproliferative activity of the crude EtOH extract, MeOH and hexane
phases, and fractions F1–F5 was evaluated on in vitro cell lines NCI-H460 (nonsmall cell lung), MCF-7 (breast cancer), and U251
(glioma). The MeOH phase showed activity (mean logGI
50
0.54) higher than the hexane phase and EtOH extract (mean logGI
50
1.13 and 1.19, resp.). F1 exhibited activity against NCI-H460 (nonsmall cell lung) (GI
50
1.2 𝜇g/mL), which could be accounted for
the presence of flavonoids and/or diterpenes. F4 showed moderate activity (mean logGI
50
1.05), while F5 showed weak activity
(mean logGI
50
1.36). It is suggested that the antiproliferative activity of the crude EtOH extract and MeOH phase is accounted for
a synergistic combination of flavonoids and diterpenes.
1. Introduction
Croton L. (Euphorbiaceae) has approximately 1300 species
of herbaceous, shrubs, trees, and lianas forms. The genus is
widely distributed in tropical and subtropical regions around
theworld, including Brazil, a countrywith 316 species, among
which 253 are endemic [1, 2].
Medicinal and toxic properties of Croton species have
been ascribed to a wide variety of chemical compounds, such
as terpenoids and steroids, alkaloids, and phenolic com-
pounds, the latter including predominantly flavonoids, lig-
nans, and proanthocyanidins [3–5].
According to the International Agency for Research on
Cancer (IARC), the world impact of cancer has more than
duplicated in the last 30 years [6]. The 2014 and 2015 annual
estimative regarding Brazil foresees the emergence of approx-
imately 576,000 new cancer cases, including nonmelanoma
skin cancer. This latter cancer type is expected to become
the most frequent among the Brazilian population (32%
new cases), followed by prostate tumors (12%), female breast
(10%), colon and rectum (6%), lung (5%), stomach (3.5%),
and cervical (3%) [7].
Among drugs currently used in cancer treatment, over
60% are products directly or indirectly derived from plants
[8]; most of them related to alkaloids and terpenoids [9].
Several studies dealing with Croton species have reported
the isolation of cytotoxic derivatives. Shoots of C. hieronymi
Griseb. showed strong activity against lung A-549 carcinoma
cells, mouse lymphoma, and human colon carcinoma [10].
The CH
2
Cl
2
extract of leaves of C. macrobothrys Baill. and
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C. zambesicusMu¨ll. Arg. showed cytotoxicity against human
lung and leukemia cells [11] and cervix carcinoma cells [12],
respectively. Ent-kaurane diterpenoids from Croton tonki-
nensis have activity against colorectal cancer cells [13]; ent-
kaur-16-ene-6a,19-diol from C. floribundus Spreng. exhibited
a moderate effect against MDA-MB-435 (melanoma), HCT-
8 (colorectal adenocarcinoma), and HCT-116 (colorectal
adenocarcinoma) cell lines [14]. Isopimara-7,15-dien-3b-ol
from C. zambesicus showed weak cytotoxic activity against
cancer (HeLa, human cervix carcinoma cells; HL-60, human
promyelocytic leukemia) and noncancer (WI-38, human
lung fibroblast) cell lines [15]. An epimer of kaurenoic acid
from C. antisyphiliticusMart. showed cytotoxic activity, with
half maximal inhibitory concentration values of 59.41, 68.18,
and 60.30 𝜇g/mL for the B-16 (murine melanoma), HeLa
(human cervix carcinoma cells), and 3T3 (normal mouse
embryo fibroblasts) cell lines, respectively [16]. These com-
pounds are considered valuable toward the development of
new and highly effective anticancer chemotherapeutic agents,
due to their efficacy toward the induction of apoptosis [17, 18].
Individuals of Croton sphaerogynus Baill. sect. Cleodora
grow in the states of Bahia, Rio de Janeiro, Espı´rito Santo, and
Sa˜o Paulo (Brazil). Most of its populations are distributed in
moist forests of seashore plains (“restinga forests”). Two other
species of this section, Croton cajucara Benth., popularly
known as “sacaca,” and Croton heterocalyx Baill., have been
traditionally exploited for their medicinal properties (e.g.,
[4, 5, 19]). CH
2
Cl
2
and hexane extracts from leaves of C.
sphaerogynus exhibited antiproliferative activity against NCI-
H460 (nonsmall cell lung) (GI
50
0.26𝜇g/mL and 0.33 𝜇g/mL,
resp.) and K562 cell lines (GI
50
0.60 𝜇g/mL and <0.25 𝜇g/mL,
resp.). These activities were related to the presence of abi-
etane, podocarpane, and clerodane diterpenes [20].
The main goal of this study was to characterize the
major polar constituents of the EtOH extract from leaves of
C. sphaerogynus and evaluate their in vitro antiproliferative
activities against tumor cell lines. This study differs from that
of Motta et al. [20], which focused on the antiproliferative
activity of diterpenes of nonpolar extracts from C. sphaerogy-
nus and thus did not deal with its flavonoid constituents and
their antiproliferative activity.
2. Material and Methods
2.1. Plant Material. Leaves of Croton sphaerogynus were
collected in January 2012, in an area of Atlantic Forest in the
municipality of Itanhae´m, State of Sa˜o Paulo (Southeastern
Brazil). A voucher specimen (LBM 65) was deposited in the
herbariumMaria Eneyda P. K. Fidalgo (SP), Sa˜o Paulo.
2.2. Extraction Procedure. Dried and powdered leaf material
(1 kg) was extracted by maceration with EtOH (5 L) for seven
days at room temperature. Crude EtOH extract (EE) was
concentrated under reduced pressure, evaporated to dryness
under a stream of nitrogen, and lyophilized, affording 70.62 g
of crude EtOH extract (yield: 7%). Part of the crude EtOH
extract (65 g) was resuspended in MeOH and partitioned
using hexane. The hexane phase (HP) was concentrated
under reduced pressure to yield 20 g (2%) of hexane phase,
while the MeOH phase (MP) was lyophilized to afford 15 g
(yield: 1.5%). Part ofMP (8 g) was fractionated over Sephadex
LH-20 using MeOH as eluent, affording five fractions: F1
(2 g), F2 (0.119 g), F3 (0.090 g), F4 (0.353 g), and F5 (0.090 g).
2.3. Chemical Analysis. All lyophilized crude EtOH extract,
MP and HP phases, and fractions (F1–F5) were dissolved in
MeOH (2mg/mL) and analyzed using a HPLC 1260 (Agilent
Technologies) chromatograph, equipped with diode array
detector (DAD) and a Zorbax-C18 (250 × 4.6mm, 3.5 𝜇m,
Agilent, USA) column at 40∘C. Solvents used were 0.1%
acetic acid (AcOH) and acetonitrile (CH
3
CN), starting with
15% of CH
3
CN (0–20min), increasing to 100% (20–25min),
isocratic (5min), and decreasing to 15% (30–32min), and iso-
cratic (3min). Solvent flow rateswere 1.5mL/min (0–25min),
1.0mL/min (25-26min), and 1.5mL/min (26–35min); injec-
tion volume was 3 𝜇L, and detection was at 352 nm and
280 nm. Quercetin and kaempferol at concentrations from
0.6 to 360 ng/mL were used to prepare calibration curves
following the same analysis conditions. Results are expressed
in milligrams per gram of dry sample (mg/g).
MeOH phase (MP) was also analyzed using a Bruker
Daltonics equipment Esquire 3000 PlusHPLCwith a Zorbax-
C18 (250 × 4.6mm, 3.5 𝜇m, Agilent, USA) column at 40∘C,
using the same conditions cited above. Solvent flow rates
was .90 𝜇L/min, voltage 4000V, nebulizer 27 psi, drying gas
at 320∘C, and flow of 7 L/min. Constituents were identified
by comparing the corresponding UV-Vis and ESI/MS-MS
spectra with MS data from the literature.
A purified compound from F5 was analyzed by 1HNMR
at 500MHz, using a Bruker DRX-500 spectrometer. DMSO-
d
6
(Aldrich) was used as solvent and the residual peak of the
nondeuterated solvent as internal standard.
2.4. Antiproliferative Assay. Cancer cell lines used were
kindly provided by the National Cancer Institute (NCI) at
Frederick MA-USA and included NCI-H460 (nonsmall cell
lung), MCF-7 (breast cancer), and U251 (glioma). Stock cell
cultures were grown in medium containing RPMI 1640,
supplemented with 5% of fetal bovine serum. Experimental
cultures were supplemented also with penicilin : streptomicin
(10 𝜇g/mL : 10UI/mL).
Cells (100 𝜇L cells/well, inoculation density from 3–6 ×
104 cell/mL) in 96-well plates were exposed to various sample
concentrations (0.25 to 250𝜇g/mL, 100 𝜇L/well) in DMSO/
RPMI 1640/FBS 5% at 37∘C, 5% of CO
2
in air for 48 h. Final
DMSO concentration did not affect cell viability. Cells were
then fixed with 50% trichloroacetic acid and cell proliferation
was determined by spectrophotometric quantification of
cellular protein content at 540 nm, using the sulforhodamine
B assay. Doxorubicin (DOX; 0.025–25𝜇g/mL) was used
as positive control. Three measurements were obtained at
the beginning of incubation (time zero, 𝑇
0
) and 48 h after
incubation for compound-free (𝐶) and tested (𝑇) cells. Cell
proliferation was determined according to the equation 100×
[(𝑇 − 𝑇
0
)/𝐶 − 𝑇
0
], for 𝑇
0
< 𝑇 ≤ 𝐶, and 100 × [(𝑇 − 𝑇
0
)/𝑇
0
],
for 𝑇 ≤ 𝑇
0
and a concentration-response curve for each
cell line was plotted using software ORIGIN 7.5 (OriginLab
Corporation) [21].
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Table 1: Major constituents of the crude EtOH extract (EE), MeOH (MP) and hexane (HP) phases, and fractions (F1–F5) from of Croton
sphaerogynus leaves, characterized by HPLC-DAD (352 nm) and HPLC-MS.
Constituent Rt (min) UV/visible (nm) Mass spectrum Suggestion
[𝑚/𝑧]
+
[𝑚/𝑧]
−
1 1.75 254, 264 (om), 348 Quercetin derivative
2 2.96 256, 264 (om), 296(om), 354 757.8; 611.1; 465; 303 755.7 Quercetin triglycoside (2 rhamnose; 1 hexose)
3 3.16 260, 296, 356 741.8; 595.1; 433.1;286.8 Kaempferol triglycoside (2 rhamnose; 1 hexose)
4 4.05 264, 292, 346 741.8; 595.1; 287 Kaempferol triglycoside (2 rhamnose; 1 hexose)
5 4.30 264, 294, 348 741.9; 595.2; 448.7;287 739.6 Kaempferol triglycoside (2 rhamnose; 1 hexose)
6 4.99 256, 266 (om), 294(om), 354 595, 303 Quercetin diglycoside (1 pentose; 1 hexose)
7 5.33 256, 266 (om), 294(om), 354 661.1; 465 608.9 Rutin
8 6.04 264, 294, 348 595, 286.9 593 Kaempferol diglycoside (1 rhamnose; 1 glucose)
9 6.35 256, 264 (om), 296(om), 354 479, 316.9 Isorhamnetin monoglycoside (1 hexose)
10 7.30 264, 294, 348 448.9; 286.9 Kaempferol monoglycoside (1 hexose)
11 9.23 264, 294, 346 Kaempferol derivative
12 10.10 256, 268 (om), 356 Quercetin derivative
13 10.72 264, 294, 346 Kaempferol derivative
14 10.97 256, 264 (om), 306(om), 348 449.0; 302.9 447 Quercitrin
15 20.44 262, 294, 340 Kaempferol derivative
16 22.95 254, 270, 298, 370 Quercetin
17∗ 23.23 256, 266 (om), 298(om), 356 317, 302 314.8 Quercetin 3-O-methyl ether
18 23.55 264, 292, 320, 366 Kaempferol
19 23.73 266, 294, 350 Kaempferol derivative
20 23.84 254, 268 (om), 294(om), 356 Quercetin derivative
Rt: average retention time in minutes. ∗Compound confirmed by 1H NMR.
2.5. Data Analysis. Using the concentration-response curve
for each cell line, GI
50
(concentration causing 50% growth
inhibition) [22] was determined by means of nonlinear
regression analysis, using software ORIGIN 7.5 (OriginLab
Corporation). The average activity (mean of log GI
50
) of the
extracts tested was also determined using MS Excel software.
Extracts were regarded as inactive (mean > 1.5), weakly (1.1 <
mean < 1.5), moderately (0 <mean < 1.1), or potently (mean <
0) active on basis of the NCI criteria for the mean of log GI
50
[23].
3. Results and Discussion
Retention times and UV and MS data analysis of the con-
stituents from the crude EtOH extract (EE),MeOH (MP) and
hexane (HP) partition phases, and fractions F1–F5 are given
inTable 1. Twenty substanceswere detected,mainly quercetin
and kaempferol derivatives. F1, F2, and F3 exhibited similar
flavonol composition. F4 contains three major compounds:
quercitrin, quercetin 3-O-methyl ether, and a kaempferol
derivative, while F5 contains quercetin 3-O-methyl ether
(Table 1, compound 17).
Comparison of spectroscopic data with those from the
literature [24] allowed the identification of compound 17
as 5,7,3󸀠,4󸀠-tetrahydroxy-3-methoxy-flavonol (quercetin-3-
O-methyl ether) (Table 1).
Flavonoids found in Croton are mostly highly methoxy-
lated aglycones, such as artemetin [3]. It has been reported
that several Croton species produce acylated flavonoids,
such as tiliroside (kaempferol-𝑝-coumaroyl glucoside) [25–
27]. Rutin (Table 1, compound 7) was also detected in the
MeOH extract from leaves of C. lechleri Mull. Arg. [28];
fresh latex of C. celtidifolius Baill. has flavonols, such as
kaempferol, quercetin, and myricetin in its composition
[29]. Savietto et al. [30] detected apigenin dihexoside and
tiliroside (kaempferol-p-coumaroyl glucoside) as ubiquitous
constituents of the MeOH leaf extract of C. dichrous Mu¨ll.
Arg., C. erythroxyloides Baill., and C. myrianthusMull. Arg.
C. sphaerogynus was previously described as a major
producer of diterpenes. Using serial extraction with hexane,
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Table 2: Antiproliferative activity (GI50, 𝜇g/mL) of the leaf extract and fractions of Croton sphaerogynus on culture cell lines.
Material tested Cell lines
a
Mean log GI
50
c
U251 MCF-7 NCI-H460
Doxorubicinb <0.025 <0.025 <0.025 −1.60 P
EE 23.4 53.4 3.00 1.19 W
MP 8.10 20.0 0.25 0.54M
HP 24.7 27.2 3.80 1.14 W
F1 16.7 20.3 1.20 1.19 W
F2 41.8 61.1 12.3 1.50 W
F3 58.7 47.0 12.4 1.51 I
F4 15.0 8.10 11.8 1.05M
F5 31.6 17.9 21.8 1.36 W
aU251: glioma; MCF-7: breast cancer; NCI-H460: nonsmall cell lung.
bPositive control. NCI’s criteria (Fouche et al., 2008 [23]): I: mean log GI50 > 1.5 = inactive; W: weak activity: mean log GI50 > 1.1–1.5; M: moderate activity:
mean log GI50 > 0–1.1; P: potent activity: mean log GI50 < 0.
clog GI50.
Crude EtOH extract (EE); MeOH (MP) and hexane (HP) phases, and fractions (F1, F2, F3, F4, and F5).
CH
2
Cl
2
, andMeOH,Motta et al. [20] identified a great diver-
sity of diterpenes, especially in the CH
2
Cl
2
extract. In the
present study, maceration with EtOH at room temperature
yielded an extract with a diterpene profile similar to that
described by Motta et al. [20]. The lyophilized crude ethanol
extract was resuspended in MeOH and partitioned with
hexane. Partition did not eliminate the diterpenes from the
polar fractionMP. Column chromatography using Sephadex
and MeOH gave five fractions (F1–F5), the first of which
(F1) contained diterpenes and flavonoids, while the further
fractions (F2–F5) contained flavonoids exclusively.
Crude EtOH extract(EE), hexane phase (HP), F1, and
F2 showedweak antiproliferative activity (Table 2).Methanol
phase (MP) and F4 showedmoderate activity, mainly against
cell lines NCI-H460 (nonsmall cell lung) (mean log GI
50
0.54
and 1.05, resp.). On the other hand, F3 was inactive, while
F5, containing virtually only quercetin-3-O-methyl ether
(Table 1, compound 17), also showed weak antiproliferative
activity (Table 2).
According toMotta et al. [20] the antiproliferative activity
of C. sphaerogynus extract was a result of the massive
presence of abietane and/or podocarpane diterpenes in
nonpolar extracts. The present study tested two different
sets of samples: extract and phases composed by different
proportions of diterpenes and flavonoids (EE, HP, MP,and
fractionF1) and fractions composed exclusively by flavonoids
(F2–F5). Table 3 compares data obtained by Motta et al.
[20] and the diterpene mixture obtained in the present
work. According to Motta et al. [20] the CH
2
Cl
2
extract
showed higher activity (mean log GI
50
0.86), compared with
hexane and MeOH extracts (mean log GI
50
1.26 and 1.49,
resp.). Regarding the diterpene profile, the latter extract
was the most similar to MP and HP phases, although
some qualitative and quantitative differences are evident. No
crotonin derivative was detected in the present study, which
may explain the moderate antiproliferative activity of the
CH
2
CL
2
extract (mean 0.86 log GI
50
) reported by Motta et
al. [20] and the weak antiproliferative activity exerted byHP.
The CH
2
Cl
2
extract from C. macrobothrys, which contains
a crotonin derivative, showed moderate antiproliferative
activity (mean log GI
50
0.89) [11]. Grynberg et al. [31] tested
trans-dehydrocrotonin and trans-crotonin isolated from C.
cajucara Benth. on the survival of mice bearing Sarcoma 180
and Ehrlich carcinoma and observed a significant antitumor
activity when mice were treated with trans-dehydrocroto-
nin.
MP phase was the most active sample, showing mod-
erate antiproliferative activity. The relative proportion of
diterpenes and flavonoids (Table 4) might be important to
enhance the antiproliferative activity. Either extracts with
high contents of diterpenes or fractions with high con-
tents of flavonoids presented weak or no antiproliferative
activity. F2, F3, and F4 (fractions lacking diterpenes) were
shown to be inactive. F1, though still containing diterpenes,
showed flavonols in smaller amount thanMP; F5, composed
virtually by quercetin-3-O-methyl ether, also showed weak
antiproliferative activity. The hexane phase (HP) contained
no detectable flavonoids. These results suggest that Croton
species lacking crotonin derivatives might have moderate
antiproliferative activity if they have a combination of other
diterpenes and flavonols.
Extracts from Croton species are frequently reported as
exerting antiproliferative activity. The essential oil from the
stem bark of C. lechleri showed mutagen-protective efficacy
[32] and crude extracts from stems of C. cajucara [19],
containing clerodane diterpenes, exert antitumor activity
against the K562 leukemic cell line. The CH
2
Cl
2
extract of
C. macrobothrys leaves, also containing clerodane diterpenes,
exhibited moderate antiproliferative activity against several
cell lines, in particular NCI-H460 (nonsmall cell lung) and
K562 (leukemia) [11].
On the other hand, flavonoids such as apigenin dihex-
oside and tiliroside (kaempferol-p-coumaroyl glucoside)
detected in leaf extract of C. dichrous, C. myrianthus, and
C. erythroxyloides showed weak or no growth cell inhibition.
However, extracts or fractions with substantial amounts
of these compounds showed weak activity [30]. However,
MeOH extract from C. erythroxyloides obtained under reflux
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Table 3: Main constituents of leaf extract and fractions from Croton sphaerogynus leaves and respective GC/EIMS data. EE: crude EtOH
extract;MP: methanol phase;HP: hexane phase; F1: fraction 1. RT: retention time (min); MM: molecular mass; N.I.: not identified.
RT (min) MM Characterization∗ Relative amount (%)
Dch∗ Met∗ EE MP HP F1
1 14.8 272 Abieta-8, 11-diene 2.2 2.3 — — 3.8 —
2 15.2 278 NI — 0.9 1.6 —
3 16.2 306 NI — — 1.3 —
4 16.4 286 Abieta-8,11-dien-3-one 20.2 20.1 36.0 22.3 27.6 23.8
5 16.7 286 Abieta-8,11,13-trien-3-ol 6.2 13.1 5.4 6.5 7.7 7.1
6 16.9 288 Abieta-8,11-dien-3-ol 3.8 16.7 4.6 8.0 3.3 8.9
7 17.2 286 Podocarp-7-en,13-methyl-13-vinyl-3-one 12.9 4.7 11.2 17.9 18.5 17.9
8 17.5 286 NI 2.1 2.5 0.9 2.7
9 17.7 288 NI 0.9 3.8 1.5 4.6
10 18.0 284 NI 3.6 1.7 1.6 1.4
11 18.1 286 NI — 1.3 1.8 1.6
12 18.2 286 NI 6.7 4.0 3.3 3.4
13 18.6 286 Abieta-8,11,13-trien-12-ol 11.9 18.5 10.3 13.9 21.8 13.5
14 19.2 288 Podocarp-7-en-3-ol, 13-methyl-13-vinyl 4.5 1.6 6.2 4.0 6.0
15 19.3 302 13-hydroxy-abieta-8,11-dien-7-one 4.8 4.2 2.1 — 1.9
16 20.3 300 11-hydroxy-abieta-8,11,13-trien-7-one 3.4 2.2 0.9 — 1.2
17 20.5 302 NI — 1.2 — 1.3
18 20.6 300 Abieta-6,8,11,13-tetraen-3,12-diol 0.7 10.2 4.8 0.7 4.2
19 21.1 286 NI — 1.2 — 0.4
20 21.2 302 Abieta-8,11,13-trien-6,14-diol 0.8 0.9 0.9 — —
21 — 316 Crotonin derivative∗ 5.2 — — — —
NI 23.4 24.6 8.8 9.7 7.1 7.8
∗Main constituents of leaf extract of Croton sphaerogynus and respective GC/EIMS data and characterization according toMotta et al. [20]. Dch, CH2Cl2; Met,
MeOH.
Table 4: Relative amount of major flavonoids in crude EtOH extract (EE), MeOH phase (MP), and fractions (F1–F5) of C. sphaerogynus,
detected by HPLC-DAD (352 nm).
Constituent∗ EE MP F1 F2 F3 F4 F5
1 nd 0.10Q — 0.47Q — — —
2 0.20Q 1.17Q 0.94Q — — — —
3 nd — — 2.23K 3.00K — —
4 0.57K 2.45K 2.01K — — — —
5 1.03K 3.73K 3.04K — — — —
6 0.09Q 0.35Q — 4.65Q 5.18Q — —
7 0.37Q 1.63Q 0.89Q 19.35Q 8.39Q — —
8 0.10K 0.51K 0.50K — — — —
9 0.09Q 0.48Q — 0.91Q 6.51Q 8.42Q —
10 0.18K 0.67K 0.48K 5.5K 1.84K — —
11 0.99K 3.04K 2.42K 19.71K 4.42K — —
12 nd — — 7.47Q 8.39Q — —
13 nd — — 4.15K — — —
14 0.51Q 3.13Q — 3.65Q 34.51Q 47.06Q —
15 nd — — 2.54K 7.89K — —
16 nd — — 2.47Q 3.68Q nd —
17 0.59Q 3.26Q 0.13Q 3.06Q 2.16Q 70.96Q 58.31Q
18 nd — — 2.94K 1.70K — —
19 0.48K 0.97K — — 2.13K 29.68K —
20 nd — — — 2.23Q nd —
∗Identification suggestions in Table 1.
QValues expressed as milligram per gram of quercetin equivalent (mg/gQE).
KValues expressed as milligram per gram of kaempferol equivalent (mg/g KE).
nd: trace amounts.
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showed moderate antiproliferative activity (mean of log GI
50
1.00) [30].
Angst et al. [33] observed that the flavonol quercetin
inhibits the growth of pancreatic cancer cell lines by induc-
ing apoptosis. The association of gemcitabine (a standard
chemotherapeutic drug administered to patients with pan-
creatic cancer) and quercetin had no additional effect when
compared with quercetin administered alone. The authors
also observed a significant apoptotic effect and reduced
tumor cell proliferation in in vivo assay using querce-
tin.
Besides synergism, the chemical structure of the fla-
vonoids seems to be directly related to their antiprolifera-
tive activity. Burmistrova et al. [34] showed that synthetic
flavonols with a hydroxyl group at the C3 position are 7-fold
more potent than flavonols with amethoxyl group at the same
position. This result suggests that a C3 methoxyl group at
C3 is a reducing factor of cytotoxicity. In the present study,
quercetin-3-O-methyl ether alone showed weak antiprolif-
erative activity (mean of log GI
50
1.36). However, according
to Seito et al. [35] flavonoids with methoxyl groups at
positions other than C3 seem to have inhibitory effect on cell
growth.
4. Conclusion
The antiproliferative activity of Croton sphaerogynus seems
to be related to the presence of diterpenes and flavonoids.
MeOH phase (MP) presented the highest antiproliferative
activity among all samples tested and is showed to be
composed by diterpenes and a high amount of flavonoids,
in comparison with the crude EtOH extract (EE) and F1.
Fractions containing no diterpenes showed weak antipro-
liferative activity. Samples containing small proportions of
flavonoids also showed weak antiproliferative activity. The
relative proportions of representatives of these two metabo-
lite classes (flavonoids and diterpenes) in C. sphaerogynus
extracts seem to be crucial to determine their antiproliferative
activity.
Conflict of Interests
The authors declare that there is no conflict of interests
regarding the publication of this paper.
Acknowledgments
The authors thank Fundac¸a˜o de Amparo a` Pesquisa do
Estado de Sa˜o Paulo (FAPESP) for financial support (FAPESP
2012/10079-0) and Frederick Cancer Research & Develop-
ment Center of theNational Cancer Institute (Frederick,MA,
USA) for the kind provision of cell lines. Antonio Salatino,
Cla´udia M. Furlan, Deborah Y. A. C. Santos, Joa˜o E. de
Carvalho, Joa˜o Henrique G. Lago, Marcelo J. Pena Ferreira,
and Maria L. F. Salatino are fellow researchers of Con-
selho Nacional de Desenvolvimento Cient´ıfico e Tecnolo´gico
(CNPq). Ka´tia Pereira Santos thanks the Coordenac¸a˜o de
Aperfeic¸oamento de Pessoal de Nı´vel Superior (CAPES) for a
Master’s research grant.
References
[1] B. W. van Ee, R. Riina, and P. E. Berry, “A revised infrageneric
classification and molecular phylogeny of new world Croton
(Euphorbiaceae),” Taxon, vol. 60, no. 3, pp. 791–823, 2011.
[2] I. Cordeiro, R. Secco, D. S. Carneiro-Torres et al., “Croton in
Lista de Espe´cies da Flora do Brasil,” Jardim Botaˆnico do Rio de
Janeiro, 2014, http://floradobrasil.jbrj.gov.br/jabot/listaBrasil/
FichaPublicaTaxonUC/FichaPublicaTaxonUC.do?id=FB17497.
[3] A. Salatino, M. L. F. Salatino, and G. Negri, “Traditional
uses, chemistry and pharmacology of Croton species (Euphor-
biaceae),” Journal of the Brazilian Chemical Society, vol. 18, no.
1, pp. 11–33, 2007.
[4] P. R. H. Moreno, M. E. L. Lima, M. B. R. Caruzo, D. S. C. Torres,
I. Cordeiro, and M. C. M. Young, “Chemical composition
and antimicrobial activity of the essential oil from Croton
heterocalyx Baill. (Euphorbiaceaes) leaves,” Journal of Essential
Oil Research, vol. 21, no. 2, pp. 190–192, 2009.
[5] F. F. Perazzo, J. C. T. Carvalho, M. Rodrigues, E. K. L. Morais,
and M. A. M. Maciel, “Comparative anti-inflammatory and
antinociceptive effects of terpenoids and an aqueous extract
obtained from Croton cajucara Benth,” Brazilian Journal of
Pharmacognosy, vol. 17, no. 4, pp. 521–528, 2007.
[6] WorldHealthOrganization,WorldCancer Report, International
Agency for Research on Cancer, Lyon, France, 2009.
[7] Instituto Nacional de Caˆncer, Estimativa 2014: incideˆncia de
caˆncer no Brasil, INCA, 2014, http://www.inca.gov.br/estima-
tiva/2014/estimativa-24042014.pdf.
[8] G. M. Cragg and D. J. Newman, “Nature: a vital source of leads
for anticancer drug development,” Phytochemistry Reviews, vol.
8, no. 2, pp. 313–331, 2009.
[9] R. Gupta, B. Gabrielsen, and S. M. Ferguson, “Nature’s
medicines: traditional knowledge and intellectual property
management. Case studies from the National Institutes of
Health (NIH), USA,” Current Drug Discovery Technologies, vol.
2, no. 4, pp. 203–219, 2005.
[10] C. A.N. Catala´n, C. S. deHeluani, C. Kotowicz, T. E. Gedris, and
W. Herz, “A linear sesterterpene, two squalene derivatives and
two peptide derivatives from Croton hieronymi,” Phytochem-
istry, vol. 64, no. 2, pp. 625–629, 2003.
[11] L. B. Motta, C. M. Furlan, D. Y. A. C. Santos et al., “Constituents
and antiproliferative activity of extracts from leaves of Croton
macrobothrys,” Brazilian Journal of Pharmacognosy, vol. 21, no.
6, pp. 972–977, 2011.
[12] S. Block, C. Ste´vigny, M.-C. de Pauw-Gillet et al., “ent-
trachyloban-3beta-ol, a new cytotoxic diterpene from Croton
zambesicus,” Planta Medica, vol. 68, no. 7, pp. 647–649, 2002.
[13] P. T. Thuong, N. M. Khoi, S. Ohta et al., “ent-kaurane diter-
penoids from Croton tonkinensis induce apoptosis in colorectal
cancer cells through the phosphorylation of JNK mediated by
reactive oxygen species anddual-specificity JNKkinaseMKK4,”
Anti-Cancer Agents in Medicinal Chemistry, vol. 14, no. 7, pp.
1051–1061, 2014.
[14] P. K. S.Uchoˆa, J. N. da Silva Jr., E. R. Silveira et al., “Trachylobane
and kaurane diterpenes fromCroton floribundus spreng,”Quim-
ica Nova, vol. 36, no. 6, pp. 778–782, 2013.
[15] S. Block, C. Baccelli, B. Tinant et al., “Diterpenes from the leaves
of Croton zambesicus,” Phytochemistry, vol. 65, no. 8, pp. 1165–
1171, 2004.
[16] V. C. Fernandes, S. I. V. Pereira, J. Coppede et al., “The epimer of
kaurenoic acid from Croton antisyphiliticus is cytotoxic toward
BioMed Research International 7
B-16 and HeLa tumor cells through apoptosis induction,” Ge-
netics andMolecular Research, vol. 12, no. 2, pp. 1005–1011, 2013.
[17] B. C. Cavalcanti, D. P. Bezerra, H. I. F.Magalha˜es et al., “Kauren-
19-oic acid induces DNA damage followed by apoptosis in
human leukemia cells,” Journal of Applied Toxicology, vol. 29, no.
7, pp. 560–568, 2009.
[18] E. Mongelli, A. B. Pomilio, J. B. Sa´nchez, F. M. Guerra, and
G. M. Massanet, “ent-Kaur-16-en-19-oic acid, a KB cells cyto-
toxic diterpenoid from Elaeoselinum foetidum,” Phytotherapy
Research, vol. 16, no. 4, pp. 387–388, 2002.
[19] M. A. M. Maciel, J. R. Martins, A. C. Pinto, C. R. Kaiser, A.
Esteves-Souza, and A. Echevarria, “Natural and semi-synthetic
clerodanes of Croton cajucara and their cytotoxic effects against
ehrlich carcinoma and human K562 leukemia cells,” Journal of
the Brazilian Chemical Society, vol. 18, no. 2, pp. 391–396, 2007.
[20] L. B.Motta, C.M. Furlan, D. Y. A. C. Santos et al., “Antiprolifera-
tive activity and constituents of leaf extracts ofCroton sphaerog-
ynus Baill. (Euphorbiaceae),” Industrial Crops and Products, vol.
50, pp. 661–665, 2013.
[21] A. Monks, D. Scudiero, P. Skehan et al., “Feasibility of a high-
flux anticancer drug screen using a diverse panel of cultured
human tumor cell lines,” Journal of theNational Cancer Institute,
vol. 83, no. 11, pp. 757–766, 1991.
[22] R. H. Shoemaker, “The NCI60 human tumour cell line anti-
cancer drug screen,” Nature Reviews Cancer, vol. 6, no. 10, pp.
813–823, 2006.
[23] G. Fouche, G. M. Cragg, P. Pillay, N. Kolesnikova, V. J. Maharaj,
and J. Senabe, “In vitro anticancer screening of South African
plants,” Journal of Ethnopharmacology, vol. 119, no. 3, pp. 455–
461, 2008.
[24] L. Krenn, A. Miron, E. Pemp, U. Petr, and B. Kopp, “Flavonoids
from Achillea nobilis L.,” Verlag der Zeitschrift fu¨r Natur-
forschung: Section C, vol. 58, no. 1-2, pp. 11–16, 2003.
[25] L. M. M. Matos, Quı´mica de espe´cies nativas de Croton L.
(Euphorbiaceae) [M.S. dissertation], Instituto de Biocieˆncias,
Universidade de Sa˜o Paulo, 2011.
[26] N. R. Athayde, Perfil quı´mico e atividades biolo´gicas de Croton
echinocarpus Baill. e Croton vulnerarius Mu¨ll. Arg. [Dissertac¸a˜o
de Mestrado], Instituto de Biocieˆncias, Universidade de Sa˜o
Paulo, 2013.
[27] C. M. Furlan, K. P. Santos, M. D. Sedano et al., “Flavonoids
and antioxidant potential of nine Argentinian species of Croton
(Euphorbiaceae),” Brazilian Journal of Botany. In press.
[28] A. J. Alonso-Castro, E. Ortiz-Sa´nchez, F. Domı´nguez et al.,
“Antitumor effect of Croton lechleri Mull. Arg. (Euphor-
biaceae),” Journal of Ethnopharmacology, vol. 140, no. 2, pp. 438–
442, 2012.
[29] F. Biscaro, E. B. Parisotto, V. C. Zanette et al., “Anticancer
activity of flavonol and flavan-3-ol rich extracts from Croton
celtidifolius latex,” Pharmaceutical Biology, vol. 51, no. 6, pp. 737–
743, 2013.
[30] J. P. Savietto, C. M. Furlan, L. B. Motta et al., “Antiproliferative
activity of methanol extracts of four species of Croton on
different human cell lines,” Revista Brasileira de Farmacognosia,
vol. 23, no. 4, pp. 662–667, 2013.
[31] N. F. Grynberg, A. Echevarria, J. E. Lima, S. S. R. Pamplona,
A. C. Pinto, and M. A. M. Maciel, “Anti-tumour activity of two
19-nor-clerodane diterpenes, trans- dehydrocrotonin and trans-
crotonin, from Croton cajucara,” Planta Medica, vol. 65, no. 8,
pp. 687–689, 1999.
[32] D. Rossi, A. Guerrini, G. Paganetto et al., “Croton lechleri
Mu¨ll. Arg. (Euphorbiaceae) stem bark essential oil as possible
mutagen-protective food ingredient against heterocyclic
amines from cooked food,” Food Chemistry, vol. 139, no. 1–4,
pp. 439–447, 2013.
[33] E. Angst, J. L. Park, A. Moro et al., “The flavonoid quercetin
inhibits pancreatic cancer growth in vitro and in vivo,” Pancreas,
vol. 42, no. 2, pp. 223–229, 2013.
[34] O. Burmistrova, M. T. Marrero, S. Este´vez et al., “Synthesis
and effects on cell viability of flavonols and 3-methyl ether
derivatives on human leukemia cells,” European Journal of
Medicinal Chemistry, vol. 84, pp. 30–41, 2014.
[35] L. N. Seito, A. L. T. G. Ruiz, D. Vendramini-Costa et al.,
“Antiproliferative activity of three methoxylated flavonoids
isolated from Zeyheria montana mart. (Bignoniaceae) leaves,”
Phytotherapy Research, vol. 25, no. 10, pp. 1447–1450, 2011.
Submit your manuscripts at
http://www.hindawi.com
Pain
Research and Treatment
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
Volume 2014
Toxins
Journal of
Vaccines
Journal of
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Antibiotics
International Journal of
Toxicology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Stroke
Research and Treatment
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Drug Delivery
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Advances in 
Pharmacological 
Sciences
Tropical Medicine
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Medicinal Chemistry
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Addiction
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Emergency Medicine 
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Autoimmune 
Diseases
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Anesthesiology 
Research and Practice
Scientifica
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Pharmaceutics
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
